Abstract
Background: Resting-state functional magnetic resonance imaging (RS-fMRI) appears as a promising imaging technique to identify early biomarkers of Alzheimer type neurodegeneration, which can be more sensitive to detect the earliest stages of this disease than structural alterations. Recent findings have highlighted interesting patterns of alteration in resting-state activity at the mild cognitive impairment (MCI) prodromal stage of Alzheimer’s disease. However, it has not been established whether RS-fMRI alterations may be of any diagnostic use at the individual patient level and whether parameters derived from RS-fMRI images add any quantitative predictive/classificatory value to standard cognitive tests (CTs). Methods: We computed a set of 444 features based on RS-fMRI and used 21 variables obtained from a neuropsychological assessment battery of tests in 29 MCI patients and 21 healthy controls. We used these indices to evaluate their impact on MCI/healthy control classification using machine learning algorithms and a 10-fold cross validation analysis. Results: A classification accuracy (sensitivity/ specificity/area under curve/positive predictive value/negative predictive value) of 0.9559 (0.9620/0.9470/ 0.9517/0.9720/0.9628) was achieved when using both sets of indices. There was a statistically significant improvement over the use of CTs only, highlighting the superior classificatory role of RS-fMRI. Conclusions: RS-fMRI provides complementary information to CTs for MCI-patient/healthy control individual classification.
Keywords: Accuracy, AD, biomarker, classification, mild cognitive impairment, MCI, neurodegeneration.
Current Alzheimer Research
Title:Integration of Cognitive Tests and Resting State fMRI for the Individual Identification of Mild Cognitive Impairment
Volume: 12 Issue: 6
Author(s): Leandro Beltrachini, Matteo De Marco, Zeike A. Taylor, Jyrki Lotjonen, Alejandro F. Frangi and Annalena Venneri
Affiliation:
Keywords: Accuracy, AD, biomarker, classification, mild cognitive impairment, MCI, neurodegeneration.
Abstract: Background: Resting-state functional magnetic resonance imaging (RS-fMRI) appears as a promising imaging technique to identify early biomarkers of Alzheimer type neurodegeneration, which can be more sensitive to detect the earliest stages of this disease than structural alterations. Recent findings have highlighted interesting patterns of alteration in resting-state activity at the mild cognitive impairment (MCI) prodromal stage of Alzheimer’s disease. However, it has not been established whether RS-fMRI alterations may be of any diagnostic use at the individual patient level and whether parameters derived from RS-fMRI images add any quantitative predictive/classificatory value to standard cognitive tests (CTs). Methods: We computed a set of 444 features based on RS-fMRI and used 21 variables obtained from a neuropsychological assessment battery of tests in 29 MCI patients and 21 healthy controls. We used these indices to evaluate their impact on MCI/healthy control classification using machine learning algorithms and a 10-fold cross validation analysis. Results: A classification accuracy (sensitivity/ specificity/area under curve/positive predictive value/negative predictive value) of 0.9559 (0.9620/0.9470/ 0.9517/0.9720/0.9628) was achieved when using both sets of indices. There was a statistically significant improvement over the use of CTs only, highlighting the superior classificatory role of RS-fMRI. Conclusions: RS-fMRI provides complementary information to CTs for MCI-patient/healthy control individual classification.
Export Options
About this article
Cite this article as:
Beltrachini Leandro, Marco De Matteo, Taylor A. Zeike, Lotjonen Jyrki, Frangi F. Alejandro and Venneri Annalena, Integration of Cognitive Tests and Resting State fMRI for the Individual Identification of Mild Cognitive Impairment, Current Alzheimer Research 2015; 12 (6) . https://dx.doi.org/10.2174/156720501206150716120332
DOI https://dx.doi.org/10.2174/156720501206150716120332 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Withdrawal Notice: Evaluation of Clinical Profile, Diagnostic Tests, And Prognosis of Crypto-coccal Meningitis in HIV Infected Patients in Western India
Infectious Disorders - Drug Targets Intraventricular Recombinant Tissue Plasminogen Activator in Treatment of Aneurysmal Intraventricular Hemorrhage: A Meta-Analysis
Current Drug Targets Conference Report: 12<sup>th</sup> International Congress on Neuroprotective Agents (ICNA), Charlottesville, VA, USA September 28, 2014-Ocobert 01, 2014
CNS & Neurological Disorders - Drug Targets Advances in the Management of Brain Tumors in Infants
Current Cancer Therapy Reviews Perspectives on Tuberculosis Pathogenesis and Discovery of Anti- Tubercular Drugs
Current Medicinal Chemistry Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases
Current Drug Therapy In Vitro and In Vivo Models of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets DLPF Targeted Repetitive Transcranial Magnetic Stimulation Improves Brain Glucose Metabolism Along with the Clinical and Electrophysiological Parameters in CBD Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets High Dose Zolpidem Induced Fetal Neural Tube Defects
Current Drug Safety Lymphocytic Choriomeningitis Virus Infection: Neglected Teratogenic Zoonosis
Current Women`s Health Reviews Cerebral Hypoperfusion During Carotid Artery Stenosis can Lead to Cognitive Deficits that may be Independent of White Matter Lesion Load
Current Neurovascular Research Perioperative Management of Intracranial Aneurysm and Subarachnoid Hemorrhage
Current Pharmaceutical Design The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies
Current Pharmaceutical Design From Cerebrospinal Fluid Pulsation to Noninvasive Intracranial Compliance and Pressure Measured by MRI Flow Studies
Current Medical Imaging White Matter Integrity in Subcortical Vascular Cognitive Impairment: A Multimodal Structural MRI Study
Current Alzheimer Research Aquaporins as Targets for Drug Discovery
Current Pharmaceutical Design Neurological Assessment of Early Infants
Current Pediatric Reviews The Valsalva Maneuver and Alzheimers Disease: Is there a link?
Current Alzheimer Research Cerebrovascular Profile Assessment in Parkinson's Disease Patients
CNS & Neurological Disorders - Drug Targets